Cannabis biz could list on stock exchanges under new congressional bill (Newsletter: March 20, 2026)
- The Centers for Medicare & Medicaid Services plans to allow up to 3 mg of THC in CBD products covered under a new insurance pilot, potentially conflicting with a recent federal hemp THC limit of 0.4 mg per container.
- Bipartisan legislation introduced would enable state-legal marijuana businesses to list on major stock exchanges and protect companies providing services to the cannabis industry from federal penalties.
- Virginia’s governor has until April 13 to decide on several marijuana bills, including those to legalize recreational sales, resentence convictions, protect parental rights, and permit medical cannabis in hospitals.
- A government-funded study concludes that alcohol and tobacco pose greater harms than marijuana, with the major cannabis-related harm stemming from illegal market criminal activity.
THC in Medicare CBD coverage plan; Marijuana bills on VA gov’s desk; IA psilocybin; Study: Cannabis safer than alcohol & tobacco
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Email address:
Your support makes Marijuana Moment possible…
Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going. Join us at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Centers for Medicare & Medicaid Services will reportedly allow up to 3 milligrams of THC in CBD products being covered under a forthcoming insurance pilot program—which could conflict with a law recently signed by President Donald Trump to recriminalize hemp products containing more than 0.4 milligrams of THC per container. Reps. Guy Reschenthaler (R-PA) and Troy Carter (D-LA) filed a bipartisan bill that would let state-legal marijuana businesses list on stock exchanges like Nasdaq and NYSE—and more broadly shield companies from being punished for providing financial, accounting, insurance, advertising or other services to the cannabis industry. Virginia Gov. Abigail Spanberger (D) has until April 13 to decide whether to sign, veto or propose amendments to several marijuana bills—including ones to legalize recreational sales, resentence past convictions, protect consumers’ parental rights and allow medical cannabis in hospitals. The Iowa Senate Health and Human Services Committee approved a House-passed bill to create a psilocybin therapy program for people with PTSD, with amendments. A new government-funded study concludes that alcohol and tobacco are more harmful to users and to society than marijuana is—and that the biggest harm associated with cannabis is “organized criminal activity” in the illegal market.
/ FEDERAL The U.S. Army is punishing a reserve officer over his ownership of a state-licensed marijuana business in New York. The Drug Enforcement Administration filed technical amendments to a rule concerning changes to the order form for Schedule I and II controlled substances. Sens. Pete Ricketts (R-NE) and Richard Blumenthal (D-CT) led a letter urging the Food and Drug Administration to schedule kratom and 7-OH. / STATES Nevada Gov. Joe Lombardo (D) appointed the executive director of the Cannabis Compliance Board as the new director of the Governor’s Office of Energy. Mississippi lawmakers sent Gov. Tate Reeves (R) bills to expand medical cannabis access and to support clinical trials on ibogaine. The Connecticut legislature’s General Law Committee approved a bill to increase THC potency limits in cannabis products. A Georgia representative filed a resolution urging that the state reschedule marijuana. A New York court ruled that state marijuana regulations are not preempted by federal law. A federal judge rejected Oregon regulators’ motion for a favorable judgement in a lawsuit challenging the state’s restrictions on psilocybin services access for homebound patients. Arizona regulators announced a recall of marijuana products due to possible contamination with aspergillus. Oklahoma regulators announced a recall of medical cannabis products over testing inaccuracies. Massachusetts regulators held a hearing on a proposal to freeze marijuana cultivation licenses. Michigan regulators published guidance on the state’s new marijuana wholesale tax. Nevada Cannabis Advisory Commission subcommittees will meet on Tuesday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL Isle of Man officials awarded the territory’s first medical cannabis business license. / SCIENCE & HEALTH A study found that “breath is an alternative, non-invasive sample matrix that holds promise for identifying recent cannabis use.” A study found that “the regular cannabis use group showed no significant impairment in driving performance 12-15 hours after last cannabis use the night before, compared to the control group.” / ADVOCACY, OPINION & ANALYSIS Americans for Safe Access published a report on medical cannabis patients’ access to organ transplants. / BUSINESS Jushi Holdings Inc. and a former chief operations officer settled a lawsuit in which he claimed he was fired in retaliation for complying with safety standards. Michigan retailers sold $234.6 million worth of legal marijuana products in February. / CULTURE Rapper Afroman won a defamation lawsuit filed by Ohio police who sued him over music videos in which he used home security footage to mock their marijuana raid of his home.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Email address: